J8515 HCPCS code: Cabergoline, oral, 0.25 mg
J8515 is the HCPCS Level II code for cabergoline, oral, 0.25 mg. Its Medicare coverage code is M (Non-covered by Medicare): Medicare does not cover this item or service.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | M — Non-covered by Medicare |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | O1E — Other drugs |
| Added | 2006-01-01 |
| Last action effective | 2006-01-01 |
What changed for J8515
- 2006-01-01: J8515 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J8515?
J8515 is the HCPCS Level II code for cabergoline, oral, 0.25 mg. Short descriptor: "Cabergoline, oral 0.25mg".
Does Medicare cover J8515?
Coverage code M — Non-covered by Medicare. Medicare does not cover this item or service.
Related J85 codes
- J8501 — Aprepitant, oral, 5 mg
- J8502 — Injection, aprepitant (aponvie), 1 mg
- J8510 — Busulfan; oral, 2 mg
- J8520 — Capecitabine, oral, 150 mg
- J8521 — Capecitabine, oral, 500 mg
- J8522 — Capecitabine, oral, 50 mg
- J8530 — Cyclophosphamide; oral, 25 mg
- J8540 — Dexamethasone, oral, 0.25 mg
- J8541 — Dexamethasone (hemady), oral, 0.25 mg
- J8560 — Etoposide; oral, 50 mg
- J8562 — Fludarabine phosphate, oral, 10 mg
- J8565 — Gefitinib, oral, 250 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J8515
- Watch J8515 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J8515
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.